Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 3, 2010, Pages 1060-1068

  Mauras, Nelly ^a   DelGiorno, Charles ^a,b   Kollman, Craig ^c   Bird, Keisha ^a   Morgan, Melissa ^a,b   Sweeten, Shawn ^a   Balagopal, Prabhakaran ^a   Damaso, Ligeia ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c JAEB CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASE; CHILD; COMORBIDITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ONSET AGE; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; THROMBOSIS; WAIST CIRCUMFERENCE;

EID: 77749240196     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1887     Document Type: Article

References (46)

1. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL 2002 CDC growth charts for the United States: methods and development. Vital Health Stat Series 11:1-190
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM 2006 Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555
3. Pinhas-Hamiel O, DolanL M, Daniels SR, Standiford D, Khoury PR, Zeitler P 1996 Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 128:608-615
4. Morrison JA, Freedman LA, Wang P, Glueck CJ 2008 Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 152:201-206
5. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH 2003 Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 157:821-827
6. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S 2004 Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362-2374
7. de Ferranti SD, Gauvreau K, Ludvig DS, Neufeld EJ, Newburger JW, Rifai N 2004 Prevalence of the metabolic syndrome in American adolescents: findings from the 3rd NHANES. Circulation 110: 2494-2497
8. Cruz ML, Weigensberg MJ, Huang TTK, Ball G, Shaibi GQ, Goran MI2004 The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 89:108-113
9. Ford ES, Ajani UA, Mokdad AH 2005 The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28:878-881
10. Zimmet P, Alberti K, George MM, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S 2007 The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 8:299-306
11. August GP, Caprio S, Fennoy I, Freemark M, Kaufman FR, Lustig RH, Silverstein JH, Speiser PW, Styne DM, Montori VM; Endocrine Society 2008 Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab 93:4576-4599
12. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith Jr SC 2009 Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and international association for the Study of Obesity. Circulation 120:1640-1645.
13. Sinaiko AR, Gomez-Marin O, Prineas RJ 1997 Relation of fasting insulin to blood pressure and lipids in adolescents and parents. Hypertension 30:1554-1559
14. Taittonen L, Uhari M, Nuutinen M, Turtinen J, Pokka T, Akerblom HK 1996 Insulin and blood pressure among healthy children. Cardiovascular risk in young Finns. Am J Hypertens 9:194-199
15. Chen W, Srinivasan SR, Elkasabany A, Berenson GS 1999 Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol 150:667-674
16. Bao W, Srinivasan SR, Berenson GS 1996 Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 93:54-59
17. Freedman DS, Mei Z, Srinivasan SR, Berenson GS, Dietz WH 2007 Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr 150: 12-17.e2
18. Berenson GS, Sirinivasan SR, Bao W, Newman WP, Tracy 3rd RE, Wattigney WA 1998 Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults.NEngl J Med 338:1650-1656
19. Srinivasan SR, Myers L, Berenson GS 2002 Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 51:204-209
20. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML 2009 Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 119:628-647
21. Weiss R, Shaw M, Savoye M, Caprio S 2009 Obesity dynamics and cardiovascular risk factor stability in obese adolescents. Pediatr Diabetes 10:360-367
22. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB1987 Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 258:1183-1186
23. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PF, Muller JE, D'Agostino Sr RB 2000 Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 102:1634-1638
24. Marquez-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrières J 2002 Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25:1371-1377
25. Bao W, Srinivasan SR, Berenson GS 1993 Plasma fibrinogen and its correlates in children from a biracial community: the Bogalusa Heart Study. Pediatr Res 33:323-326
26. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW 1997 Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 82:4196-4200
27. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F 1999 Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 99:2221-2222
28. Danesh J, Collins R, Appleby P, Peto R 1998 Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279:1477-1482
29. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB 1999 Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135
30. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW 1999 C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19: 972-978
31. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB 2001 Low-grade systemic inflammation in overweight children. Pediatrics 107:E13
32. Juhan-Vague I, Alessi MC, Morange PE 2000 Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med 32(Suppl 1):78-84
33. Hoffstedt J, Andersson IL, Persson L, Isaksson B, Arner P 2002 The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity. Diabetologia 45:584-587
34. Viitanen L, Pihlajamäki J, Halonen P, Lehtonen M, Kareinen A, Lehto S, Laakso M 2001 Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease. Atherosclerosis 157:57-64
35. Balagopal P, George D, Patton N, Yarandi H, Roberts WL, Bayne E, Gidding S 2005 Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr 146:342-348
36. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG 2008 Genetically elevated C reactive protein and ischemic vascular disease. N Engl J Med 359:1897-1908
37. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group 2008 Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207
38. Mora S, Musunuru K, Blumenthal RS 2009 The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. Clin Chem 55:219-228
39. Balagopal P, Sweeten S, Mauras N 2002 Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. Am J Physiol Endocrinol Metab 282:E899-E904
40. Balagopal P, George D, Sweeten S, Mann KJ, Yarandi H, Mauras N, Vaughan DE 2008 Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D-dimer and fibrinolytic balance to physical activity-based intervention in obese children. J Thromb Haemost 6:1296-1303
41. Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL, McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB 2004 Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53: 336-346
42. Wissler RW, Strong JP 1998 Risk factors in the progression of atherosclerosis in youth. Am J Path 153:1023-1033
43. Baker JL, Olsen LW, Sorensen TI 2007 Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357:2329-2337
44. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L 2007 Adolescent overweight and future coronary artery disease. N Engl J Med 357:2371-2379
45. Aggoun Y, Farpour-Lambert NJ, Marchand LM, Golay E, Maggio AB, Beghetti M 2008 Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure. Eur Heart J 29:792-799
46. Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I 2009 Human CRP induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 206:61-68